Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prazosin for Agitation in Alzheimer's Disease
NCT01126099Phase 2Completed
- Sponsor
- Seattle Institute for Biomedical and Clinical Research
- Start
- Mar 2010
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prazosin in Alzheimer's disease (AD), sponsored by Seattle Institute for Biomedical and Clinical Research. Started Mar 2010; status: completed.
02
Drugs
prazosin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01126099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01126099.